Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8820677 | Revue des Maladies Respiratoires Actualités | 2017 | 4 Pages |
Abstract
Small cell lung cancer accounts for about 13% of all lung cancers. While its sensitivity to first-line chemotherapy is high, it is characterized by a particularly high relapse rate. The objective of this paper is to review the therapeutic options available today for patients with relapsed small cell lung cancer and to highlight the most promising experimental treatments.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
L. Greillier, N. Baize, C. Chouaïd,